318 related articles for article (PubMed ID: 38288377)
1. Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma.
An F; Chang W; Song J; Zhang J; Li Z; Gao P; Wang Y; Xiao Z; Yan C
J Bone Oncol; 2024 Feb; 44():100521. PubMed ID: 38288377
[TBL] [Abstract][Full Text] [Related]
2. The roles of glycolysis in osteosarcoma.
Feng Z; Ou Y; Hao L
Front Pharmacol; 2022; 13():950886. PubMed ID: 36059961
[TBL] [Abstract][Full Text] [Related]
3. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
4. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.
Sheng G; Gao Y; Ding Q; Zhang R; Wang T; Jing S; Zhao H; Ma T; Wu H; Yang Y
J Transl Med; 2023 Feb; 21(1):132. PubMed ID: 36803784
[TBL] [Abstract][Full Text] [Related]
5. Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets.
Zheng X; Ma H; Wang J; Huang M; Fu D; Qin L; Yin Q
Transl Oncol; 2022 Dec; 26():101534. PubMed ID: 36113343
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of long noncoding RNAs in enzymes related intracellular metabolic pathways in cancer biology.
Yu J; Zhang Y; Xue Y; Pei H; Li B
Biomed Pharmacother; 2024 Jun; 176():116831. PubMed ID: 38824835
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells.
Sreedhar A; Zhao Y
Biomed Rep; 2018 Jan; 8(1):3-10. PubMed ID: 29399334
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Landscape of Osteosarcoma: Reprogramming of Lactic Acid Metabolism and Metabolic Communication.
Wang L; Dou X; Xie L; Zhou X; Liu Y; Liu J; Liu X
Front Biosci (Landmark Ed); 2024 Feb; 29(2):83. PubMed ID: 38420794
[TBL] [Abstract][Full Text] [Related]
9. Autonomous glucose metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy.
Huang M; Yang L; Peng X; Wei S; Fan Q; Yang S; Li X; Li B; Jin H; Wu B; Liu J; Li H
J Exp Clin Cancer Res; 2020 Sep; 39(1):185. PubMed ID: 32928258
[TBL] [Abstract][Full Text] [Related]
10. Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism.
Subramaniam S; Jeet V; Clements JA; Gunter JH; Batra J
Clin Chem; 2019 Sep; 65(9):1090-1101. PubMed ID: 31101638
[TBL] [Abstract][Full Text] [Related]
11. Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells.
Wang K; Lu Y; Li H; Zhang J; Ju Y; Ouyang M
Cancer Cell Int; 2024 Jan; 24(1):15. PubMed ID: 38184562
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
Pang Y; Lu T; Xu-Monette ZY; Young KH
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982568
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNAs: Key regulators involved in metabolic reprogramming in cancer (Review).
Liu C; Li H; Chu F; Zhou X; Xie R; Wei Q; Yang S; Li T; Liang S; Lü M
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760177
[TBL] [Abstract][Full Text] [Related]
14. IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells.
He Q; Hao P; He G; Mai H; Liu W; Zhang W; Zhang K; Zhong G; Guo R; Yu C; Li Y; Wong C; Chen Q; Chen Y
J Transl Med; 2022 Aug; 20(1):348. PubMed ID: 35918761
[TBL] [Abstract][Full Text] [Related]
15. Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance.
Lei P; Wang W; Sheldon M; Sun Y; Yao F; Ma L
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444501
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis.
Ren L; Hong ES; Mendoza A; Issaq S; Tran Hoang C; Lizardo M; LeBlanc A; Khanna C
Oncotarget; 2017 Jun; 8(24):38541-38553. PubMed ID: 28404949
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming of immune cells in pancreatic cancer progression.
Xiang H; Yang R; Tu J; Xi Y; Yang S; Lv L; Zhai X; Zhu Y; Dong D; Tao X
Biomed Pharmacother; 2023 Jan; 157():113992. PubMed ID: 36395610
[TBL] [Abstract][Full Text] [Related]
18. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study.
Alcarraz-Vizán G; Sánchez-Tena S; Moyer MP; Cascante M
Biochim Biophys Acta; 2014 Jun; 1840(6):1634-9. PubMed ID: 24368265
[TBL] [Abstract][Full Text] [Related]
19. Tumor glycolysis, an essential sweet tooth of tumor cells.
Paul S; Ghosh S; Kumar S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1216-1230. PubMed ID: 36330953
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming in renal cancer: Events of a metabolic disease.
Chakraborty S; Balan M; Sabarwal A; Choueiri TK; Pal S
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188559. PubMed ID: 33965513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
